26.06.2013 | TechNarts has presented ITS in Switzerland |
TechNarts has presented ITS in Switzerland Attending the Pharmaceutical Packaging and Labelling Summit 2013 on 26 - 28 June, 2013 in Basel, Switzerland, Nart Informatics - techNarts has presented the Turkish Pharmaceutical Track & Trace System (ITS) and the situation of Turkey in the field.
Top level delegates from Global Standards One (GS1), Pharmaceutical Group of the European Union (PGEU), European Federation of Pharmaceutical Industries and Associations (EFPIA), European Directorate for the Quality of Medicines (EDQM), Novartis, Teva, SICPA, Antares Vision and Boehringer have attended the meeting. Presentations and discussions have been made on serialization, track & trace, situation of the countries in the field, future plans and actions to be taken. Furthermore, experiences gained from track & trace, serialization, implementation etc. has presented to the attendees.
Taha Yaycı, CEO and Y. Nasuh Erturan, Business Analyst from TechN’arts, has attended the summit and negotiated about ITS. In the “ITS: Situation in Turkey” titled presentation, Taha Yaycı has informed the attendees about the situation in Turkey before ITS, ITS implementation process, achievements, gained experiences, and future plans. Attendees have followed the presentation with great interest, expressed their pleasures and stated that Turkey is inspiring and encouraging them for ITS alike implementation for their countries. At the summit, once again, showing up that Turkey is far beyond the Europe and USA on serialization and pharmaceutical track & trace, TechN’arts has replied the questions of the attendees, and stated that he is ready to any kind of help on ITS alike systems planned to be implemented in Europe and USA.
|
ITS | Documentation | Support and Contact | Links |
---|---|---|---|
- What is ITS? - ITS Workflow - ITS at a Glance |
- Guides - PTS Documents - Reference Web Services |
- Contact Us |
- Announcement - Events - ITS on Press |
© 2013 TechN’arts. All Rights Reserved | Legal Notice |
||